Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19
Fatema Hersi, Anusha Sebastian, Hamadeh Tarazi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 254, pp. 115380-115380
Open Access | Times Cited: 16

Showing 16 citing articles:

Discovery of Pyrano[2,3-c]pyrazole Derivatives as Novel Potential Human Coronavirus Inhibitors: Design, Synthesis, In Silico, In Vitro, and ADME Studies
Abdou K. Allayeh, Aliaa H. El-boghdady, Mohamed A. Said, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 198-198
Open Access | Times Cited: 5
Design, synthesis, docking, and antiviral evaluation of some novel pyrimidinone-based α-aminophosphonates as potent H1N1 and HCoV-229E inhibitors
Hend A. Hekal, Omar M. Hammad, Nasser R. El‐Brollosy, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107353-107353
Closed Access | Times Cited: 5
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang Yang, Fang Li, Lanying Du
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
Complexity‐to‐Diversity and Pseudo‐Natural Product Strategies as Powerful Platforms for Deciphering Next‐Generation Therapeutics
Bilal O. Alkubaisi, Afnan I. Shahin, Ruba A. Zenati, et al.
ChemMedChem (2023) Vol. 18, Iss. 14
Closed Access | Times Cited: 8
Fabrication of functional diatomaceous earth with enhanced papain enzyme adsorption
Yuki Ide, Yuji Matsukawa
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 701, pp. 134888-134888
Open Access | Times Cited: 2
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update
Md. Easin Mia, Mithu Howlader, Farzana Akter, et al.
Clinical Pathology (2024) Vol. 17
Open Access | Times Cited: 2
Molecular Investigations of Novel Pyrano[2,3-c]Pyrazole Congeners as Potential HCoV-229E Inhibitors: synthesis, Molecular Modeling, 3D QSAR, and ADMET Screening
Mohamed G. Abouelenein, Aliaa H. El-boghdady, Hadeer M. Ali, et al.
Polycyclic aromatic compounds (2024), pp. 1-18
Closed Access | Times Cited: 2
In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus
Natália Ferreira de Sousa, Gabrielly Diniz Duarte, Carolina Borsoi Moraes, et al.
(2024)
Open Access | Times Cited: 1
Novel compounds with dual inhibition activity against SARS-CoV-2 critical enzymes RdRp and human TMPRSS2
Sameh S. M. Soliman, Alshaimaa M. Hamoda, Yogendra Nayak, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116671-116671
Closed Access | Times Cited: 1
Synthesis, biological activity, and molecular dynamic studies of new triazolopyrimidine derivatives
Sherif S. Ragab, Noha E. Ibrahim, Mohamed S. Abdel‐Aziz, et al.
Results in Chemistry (2023) Vol. 6, pp. 101163-101163
Open Access | Times Cited: 3
Fabrication of Functional Diatomaceous Earth with Enhanced Papain Enzyme Adsorption
Yuki Ide, Yuji Matsukawa
(2024)
Closed Access
In Silico and In Vitro Studies of Terpenes from the Fabaceae Family Using the Phenotypic Screening Model against the SARS-CoV-2 Virus
Natália Ferreira de Sousa, Gabrielly Diniz Duarte, Carolina Borsoi Moraes, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 912-912
Open Access
How many organic small molecules might be used to treat COVID-19? From natural products to synthetic agents
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2024) Vol. 278, pp. 116788-116788
Closed Access
Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental Validation
Bruna K. P. Sousa, Melina Mottin, Donald Seanego, et al.
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 12, pp. 2140-2149
Open Access
Phthalimide derivatives as a new class of papain‐like protease inhibitors in SARS‐CoV‐2
Thomas Fischer, David Frasson, Martin Sievers, et al.
Archiv der Pharmazie (2024)
Closed Access
Page 1

Scroll to top